下大静脈巨大血栓を合併した先天性アンチトロンビンIII欠乏症の1例

書誌事項

タイトル別名
  • A case of congenital antithrombin III deficiency complicated by giant thrombus of postcava.

説明

We succeeded in an anticoagulant therapy of a postcaval giant thrombus in a 14 year old male with a heterozygous AT III deficiency. The diagnosis of AT III deficiency was confirmed by laboratory findings of him and his family members on the neneth hospital week (Table 1, 2, Fig. 1). He was initially treated with gabexate mesilate, and then with AT III concentrate and warfarin. These treatments brought remarkable improvement of his clinical status and labolatory findings (Fig. 2). Four months after initiation of the treatment with AT III concentrate and warfarin, the thrombus of postcava disappeared. These results suggested that therapy with AT III concentrate and warfarin was effective not only in acute phase but in subacute phase of thrombosis in AT III deficiency.<br>Furthermore we examined FDP-E, FDP-D dimer, TAT complex and plasmin-α2PI complex in nine relatives with heterozygous AT III deficiency who had not experienced thrombotic problems (Table 3). Abnormal values were observed in eight of nine on TAT complex, seven of nine on Plm-α2PI complex, four of nine on FDP-E, and two of nine on FDP-D dimer. These data revealed latent hypercoagulable states in some of these patients. And consequently, analysis of these markers might be useful to detect the risk of thrombosis in AT III deficiency.

収録刊行物

  • 血液と脈管

    血液と脈管 20 (4), 350-355, 1989

    一般社団法人 日本血栓止血学会

詳細情報 詳細情報について

  • CRID
    1390001204859521408
  • NII論文ID
    130004092610
  • DOI
    10.2491/jjsth1970.20.350
  • ISSN
    18842372
    03869717
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ